Khalafallah Alhossain A, Renu Shamsunnaher, Sharp Colin, Hannan Terry
Department of Haematology and Pathology, Launceston General Hospital, Launceston, Tasmania, Australia.
BMJ Case Rep. 2012 Nov 15;2012:bcr2012007313. doi: 10.1136/bcr-2012-007313.
We report a case of an incidental finding of congenital absence of the intrahepatic segment of the inferior vena cava (IVC) complicated by extensive bilateral deep venous thrombosis (DVT) with significant oedema following a long-distance road trip. Initially the patient failed treatment with standard anticoagulation therapy with enoxaparin and warfarin. However, he has responded to the new oral antifactor-Xa anticoagulant (rivaroxaban). Within a few days, rivaroxaban improved the oedema and DVT. The significant features of this case are the unusual presentation, the poor response to initial standard anticoagulation therapy and the beneficial outcomes when managed with the novel new anticoagulant. The patient has continued the new treatment regularly for the last 12 months with good toleration and without side effects. This report presents the findings, management and outcomes in a case of extensive bilateral DVT in a previously healthy young man who was found to have a congenital short IVC.
我们报告一例偶然发现先天性肝内段下腔静脉(IVC)缺如的病例,该患者在长途驾车旅行后并发广泛双侧深静脉血栓形成(DVT)并伴有明显水肿。最初,患者接受依诺肝素和华法林标准抗凝治疗无效。然而,他对新型口服抗Xa因子抗凝药(利伐沙班)有反应。数天内,利伐沙班改善了水肿和DVT。该病例的显著特点是表现不寻常、对初始标准抗凝治疗反应不佳以及使用新型抗凝药治疗时取得了有益的结果。在过去12个月里,患者持续规律接受新治疗,耐受性良好且无副作用。本报告介绍了一名此前健康的年轻男性,被发现先天性IVC短并发生广泛双侧DVT的病例的检查结果、治疗及预后情况。